Search research articles
Contact Us
Filters
Showing results (311-320 of 319) with videos related to
Page
of 32
Sort By:
You have reached the last page of results.
This site can display upto 319 results.
British Journal of Pharmacology
|
August 24, 2012
Protein engineering and preclinical development of a GM-CSF receptor antibody for the treatment of rheumatoid arthritis
R R Minter, E S Cohen, B Wang, et al.
JAMA Network Open
|
August 8, 2025
A Digital Therapeutic Intervention for Inpatients With Elevated Suicide Risk: A Randomized Clinical Trial
Craig J Bryan, Patricia Simon, Samuel T Wilkinson, et al.
Molecular Psychiatry
|
October 5, 2018
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
Maurizio Fava, Marlene P Freeman, Martina Flynn, et al.
Molecular Psychiatry
|
January 9, 2019
Correction: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
Maurizio Fava, Marlene P Freeman, Martina Flynn, et al.
Journal of Cardiac Failure
|
June 24, 2021
The Impact of Depression on Outcomes in Patients With Heart Failure and Reduced Ejection Fraction Treated in the GUIDE-IT Trial
Fouad Chouairi, Michael A Fuery, Clancy W Mullan, et al.
JAMA Network Open
|
June 25, 2024
Ketamine vs Electroconvulsive Therapy for Treatment-Resistant Depression: A Secondary Analysis of a Randomized Clinical Trial
Manish Kumar Jha, Samuel T Wilkinson, Kamini Krishnan, et al.
The Journal of Clinical Psychiatry
|
April 22, 2020
Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression: Assessment of Long-Term Safety in a Phase 3, Open-Label Study (SUSTAIN-2)
Ewa Wajs, Leah Aluisio, Richard Holder, et al.
The New England Journal of Medicine
|
May 24, 2023
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression
Amit Anand, Sanjay J Mathew, Gerard Sanacora, et al.
Molecular Psychiatry
|
September 7, 2022
International pooled patient-level meta-analysis of ketamine infusion for depression: In search of clinical moderators
Rebecca B Price, Nicholas Kissel, Andrew Baumeister, et al.
Page
of 32
Search research articles
Search
Showing results (311-320 of 319) with videos related to
Sort By:
Page
of 32
You have reached the last page of results.
This site can display upto 319 results.
British Journal of Pharmacology
|
August 24, 2012
Protein engineering and preclinical development of a GM-CSF receptor antibody for the treatment of rheumatoid arthritis
R R Minter, E S Cohen, B Wang, et al.
JAMA Network Open
|
August 8, 2025
A Digital Therapeutic Intervention for Inpatients With Elevated Suicide Risk: A Randomized Clinical Trial
Craig J Bryan, Patricia Simon, Samuel T Wilkinson, et al.
Molecular Psychiatry
|
October 5, 2018
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
Maurizio Fava, Marlene P Freeman, Martina Flynn, et al.
Molecular Psychiatry
|
January 9, 2019
Correction: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
Maurizio Fava, Marlene P Freeman, Martina Flynn, et al.
Journal of Cardiac Failure
|
June 24, 2021
The Impact of Depression on Outcomes in Patients With Heart Failure and Reduced Ejection Fraction Treated in the GUIDE-IT Trial
Fouad Chouairi, Michael A Fuery, Clancy W Mullan, et al.
JAMA Network Open
|
June 25, 2024
Ketamine vs Electroconvulsive Therapy for Treatment-Resistant Depression: A Secondary Analysis of a Randomized Clinical Trial
Manish Kumar Jha, Samuel T Wilkinson, Kamini Krishnan, et al.
The Journal of Clinical Psychiatry
|
April 22, 2020
Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression: Assessment of Long-Term Safety in a Phase 3, Open-Label Study (SUSTAIN-2)
Ewa Wajs, Leah Aluisio, Richard Holder, et al.
The New England Journal of Medicine
|
May 24, 2023
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression
Amit Anand, Sanjay J Mathew, Gerard Sanacora, et al.
Molecular Psychiatry
|
September 7, 2022
International pooled patient-level meta-analysis of ketamine infusion for depression: In search of clinical moderators
Rebecca B Price, Nicholas Kissel, Andrew Baumeister, et al.
Page
of 32